|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
- World - - - , -
- -
Applied Spectral Imaging - Migdal Ha'Emek, Israel
- imaging systems for the life sciences
Asinex - Moscow, Russia
- compound library services
AstraZeneca - London, UK; Boston, MA
- international large pharmaceutical company; human disease therapeutics
Biacore - Uppsala, Sweden; worldwide
- instrumentation for measuring biomolecular interactions
Bristol-Meyers Squibb - New York, NY
- large pharma
Bruker Biospin - Billerica, MA
- magnetic resonance life science tools
Cartela - Lund, Sweden
- integrin-based therapeutics
Chiasma - Georgetown, MA ; Jerusalem, Israel (R&D)
- oral delivery of large molecule therapeutics
Compugen - Tel Aviv, Israel
- bioinformatic software
DakoCytomation - Glostrup, Denmark; multiple sales locations
- biochemical reagents and diagnostics
deCODE Genetics - Reykjavik, Iceland
- population-based genomics research, commercial services and consumer services
DNA Phenomics - Kuala Lumpur, Malaysia
- genomic-based personalized medical solutions for Asia and the Pacific
Electric Genetics - Reston, VA ; Cape Town, South Africa
- computational genomics for the generation of drug targets
Enamine - Kiev, Ukraine
- discovery chemistry libraries and services for pharmaceutical and agbiotech companies
Ester Neurosciences - Herzlia Pituach, Israel
- therapeutics for neurological disorders
Ethrog Biotechnologies - Ness Ziona, Israel
- life science reagents
Evogene - Rehovot, Israel
- agricultural genomics subsidiary of Compugen
Gamida-Cell - Jerusalem, Israel
- stem cell therapeutics
Gema Biotech - Buenos Aires, Capital Federal, Argentina
- genomics-driven drug discovery and nucleic acid synthesis
GeneGo - St. Joseph, MI ; Moscow, Russia
- pathway elucidation (systems biology) software
Glycominds - Lod, Israel
- glycan-based autoimmune and inflammatory diagnostics and therapeutic tools
Iceland Genomics - Reykjavik, Iceland
- genomics and genealogical-based target discovery
InterBioscreen - Moscow, Russia
- chemical library and screening services
Ipsat Therapies - Espoo, Finland
- prevention of antibiotic resistance
Jurilab - Kuopio, Finland
- genetic and genomic services based on the Eastern Finnish founder population
Keryx Biopharmaceuticals - New York, NY ; Jerusalem, Israel
- drug discovery based on protein kinases
MDS Pharma Services - King of Prussia, PA
- drug discovery services
Mindset BioPharmaceuticals - Jerusalem, Israel
- small molecule and antibody-based Alzheimerís disease therapeutics
MultiGene Vascular Systems - Haifa, Israel
- autologous somatic cell therapeutics for the treatment of vascular diseases
NeuroTrax - Newark, NJ ; Modiin, Israel
- computerized system for cognitive testing
Optimata - Ramat-Gan, Isreal
- drug treatment optimization software
Otava Chemicals - Kyiv 187, Ukraine
- custom compound synthesis
Outsourcing Clinical Trials (OCT) - Saint Petersburg, Russia
- CRO for clinical trials
Pioneer Hi-Bred - Johnston, IA
- agricultural subsidiary of DuPont
Pluristem Life Sciences - Haifa, Israel
- stem cell growth technology
Prescott Pharmaceuticals - ,
- pharmaceutical company focusing on making money and the expense of patients
Prokaria - ReykjavÌk, Iceland
- environmental gene discovery
Proneuron Biotechnologies - Los Angeles, CA ; Ness-Ziona, Israel
- CNS disease drug development
Proteologics - Rehovot, Israel
- ubiquitin-mediated disease therapeutics
Quantum Pharmaceuticals - Moscow, Russia
- drug discovery company
QuantumLead - Chernogolovka, Russia; Moscow, Russia
- compound libraries
Quark Biotech - Fremont, CA Cleveland, OH; Chicago, IL; Pleasanton, CA; Israel
- genomics-based drug discovery and development
Rosetta Genomics - Jerusalem, Israel
- genomic data analysis
Scandinavian Gene Synthesis - Kping, Sweden
- oligonucleotide synthesis
Syngenta - Basel, Switzerland; worldwide
- large agribusiness
Teva Pharmaceutical Industries - Jerusalem, Israel
- fully integrated pharmaceutical company focusing on generic drugs
XTL Biopharmaceuticals - Rehovot, Israel; Newton, MA; Durham, NC
- human disease therapeutics based on humanized monoclonal antibodies and tissue-based disease models
|
|